| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |